a month ago
INSM
AnalystsJason ZemanskyJason Zemansky's Stock Forecasts
AnalystsJason Zemansky
Sectors:
Analyst Ranking
Top 12%
#556 out of 4868 analysts
Average Return
+25.68%
Win Rate
65%17 out of 26
Risk vs Reward
Poor
Good
Jason Zemansky's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Insmed IncINSM | +197.14% | $27.28 | $81.06 | 2024-02-22 - 2025-02-21 | Strong Buy |
Werewolf Therapeutics IncHOWL | +180.18% | $2.17 | $6.08 | 2023-03-22 - 2024-03-22 | Strong Buy |
Insmed IncINSM | +175.86% | $26.43 | $72.91 | 2023-09-05 - 2024-09-05 | Strong Buy |
Esperion Therapeutics IncESPR | +118.25% | $1.37 | $2.99 | 2023-06-14 - 2024-06-14 | Strong Buy |
Werewolf Therapeutics IncHOWL | +71.77% | $2.94 | $5.05 | 2023-05-11 - 2024-05-10 | Strong Buy |
Jason Zemansky Analyst Color
Get additional color on Jason Zemansky's coverage of popular stocks
7 months ago
INSM
9 months ago
SNDX
10 months ago
INSM
a year ago
INSM
Jason Zemansky's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cytokinetics IncCYTK | 4 | Hold | $54.00 | +26.05% | Maintains | 16 days ago |
Insmed IncINSM | 9 | Strong Buy | $96.00 | +33.33% | Maintains | a month ago |
Arcus Biosciences IncRCUS | 5 | Hold | $17.00 | +94.29% | Maintains | 2 months ago |
Kura Oncology IncKURA | 2 | Strong Buy | $29.00 | +342.07% | Maintains | 5 months ago |
Syndax Pharmaceuticals IncSNDX | 3 | Strong Buy | $31.00 | +119.08% | Maintains | 9 months ago |
Esperion Therapeutics IncESPR | 5 | Sell | $2.50 | +150.25% | Downgrades | 10 months ago |
Kalaris Therapeutics IncKLRS | 2 | Sell | $23.00 | N/A | Downgrades | a year ago |
Onkure Therapeutics IncOKUR | 1 | Strong Buy | $230.00 | N/A | Initiates Coverage On | 2 years ago |
Werewolf Therapeutics IncHOWL | 4 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Q32 Bio IncQTTB | 1 | Strong Buy | $162.00 | N/A | Maintains | 3 years ago |
Allakos IncALLK | 1 | Strong Buy | $155.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.